Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells
Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells
复制标题
DOI:
10.1677/jme.0.0320859
复制
发表时间:
2004-06-01
影响因子:
3.5
通讯作者:
Elmlinger, MW
中科院分区:
文献类型:
--
作者:
Schütt, BS;Langkamp, M;Elmlinger, MW
The neoplastic production of the insulin-like growth factor binding protein (IGFBP)-2 often correlates with tumor malignancy and aggressiveness. Since IGFBP-2 contains an RGD motif in its C-terminus, it was hypothesized that this protein may act independently of IGF on tumor cells through integrins. To investigate this, integrin binding, intracellular signaling and the impact of IGFBP-2 on cell adhesion and proliferation were examined in two tumor cell lines. In tracer displacement studies, up to 30% of the added I-125-hIGFBP-2 specifically bound to the cells. Bound I-125-hIGFBP-2 was reversibly displaced by IGFBP-2, IGFBP-1 and RGD-(Gly-Arg-Asp)-containing peptides, but not by IGFBP-3, -4, -5, -6 and RGE-(Gly-Arg-Glu)-coritaining peptides. Blocking with antibodies directed against different integrins and with fibronectin demonstrated that IGFBP-2 cell surface binding is specific for alpha5beta1-integrin. Incubation of IGFBP-2 with equimolar quantities of IGF-I and IGF-II annihilated RGD-specific binding. IGFBP-2 binding at the cell surface led to dephosphorylation of the focal adhesion-kinase (FAK) of up to 37% (P